lipotropic injections with tirzepatide Semaglutide vs Tirzepatide: Skinny Shots and Weight Loss Options Tirzepatide Jacksonville - Weight Loss

Current FDA labels document these patterns in detail: Wegovy (semaglutide) lists nausea (44% vs 16% placebo), vomiting (25% vs 6%), diarrhea (30% vs 16%), constipation (24% vs 11%), abdominal distension and eructation, with severe GI events in 4.1% versus 0.9% placebo.[2] Zepbound (tirzepatide) lists nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, eructation, and gastroesophageal reflux disease among common adverse reactions, with severe GI disease as a Warnings and Precautions item.[3] Both labels include postmarketing reports of ileus, severe constipation including fecal impaction, and acute kidney injury related to dehydration from severe GI symptoms

Take Abridge, best known for tech that listens to patient-doctor conversations and writes them up as clinical notes

Each patient has different weight management needs and health situations, therefore selecting between Semaglutide GLP-1, Ozempic, Wegovy, and Mounjaro depends on those factors

One combination that raises patient questions is taking metformin and Ozempic together

For patients who may need both medication and surgery, which one should we recommend first